<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34973105</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>269</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>A perspective on persistent toxicants in veterans and amyotrophic lateral sclerosis: identifying exposures determining higher ALS risk.</ArticleTitle><Pagination><StartPage>2359</StartPage><EndPage>2377</EndPage><MedlinePgn>2359-2377</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-021-10928-5</ELocationID><Abstract><AbstractText>Multiple studies indicate that United States veterans have an increased risk of developing amyotrophic lateral sclerosis (ALS) compared to civilians. However, the responsible etiological factors are unknown. In the general population, specific occupational (e.g. truck drivers, airline pilots) and environmental exposures (e.g. metals, pesticides) are associated with an increased ALS risk. As such, the increased prevalence of ALS in veterans strongly suggests that there are exposures experienced by military personnel that are disproportionate to civilians. During service, veterans may encounter numerous neurotoxic exposures (e.g. burn pits, engine exhaust, firing ranges). So far, however, there is a paucity of studies investigating environmental factors contributing to ALS in veterans and even fewer assessing their exposure using biomarkers. Herein, we discuss ALS pathogenesis in relation to a series of persistent neurotoxicants (often emitted as mixtures) including: chemical elements, nanoparticles and lipophilic toxicants such as dioxins, polycyclic aromatic hydrocarbons and polychlorinated biphenyls. We propose these toxicants should be directly measured in veteran central nervous system tissue, where they may have accumulated for decades. Specific toxicants (or mixtures thereof) may accelerate ALS development following a multistep hypothesis or act synergistically with other service-linked exposures (e.g. head trauma/concussions). Such possibilities could explain the lower age of onset observed in veterans compared to civilians. Identifying high-risk exposures within vulnerable populations is key to understanding ALS etiopathogenesis and is urgently needed to act upon modifiable risk factors for military personnel who deserve enhanced protection during their years of service, not only for their short-term, but also long-term health.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Re</LastName><ForeName>Diane B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Department of Environmental Health Science, Center for Motor Neuron Biology and Disease, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Beizhan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Geochemistry, Lamont-Doherty Earth Observatory of Columbia University, Palisades, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calder&#xf3;n-Garcidue&#xf1;as</LastName><ForeName>Lilian</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department Biomedical Sciences, College of Health, University of Montana, Missoula, MT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad del Valle de M&#xe9;xico, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrew</LastName><ForeName>Angeline S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Neurology, Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tischbein</LastName><ForeName>Maeve</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stommel</LastName><ForeName>Elijah W</ForeName><Initials>EW</Initials><Identifier Source="ORCID">0000-0002-3079-3123</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA. Elijah.W.Stommel@hitchcock.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 ES009089</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004781" MajorTopicYN="N">Environmental Exposure</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008889" MajorTopicYN="Y">Military Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014728" MajorTopicYN="Y">Veterans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Etiology</Keyword><Keyword MajorTopicYN="N">Exposure</Keyword><Keyword MajorTopicYN="N">Neurotoxicant</Keyword><Keyword MajorTopicYN="N">Persistent</Keyword><Keyword MajorTopicYN="N">Veterans</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>1</Day><Hour>12</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34973105</ArticleId><ArticleId IdType="pmc">PMC9021134</ArticleId><ArticleId IdType="doi">10.1007/s00415-021-10928-5</ArticleId><ArticleId IdType="pii">10.1007/s00415-021-10928-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rowland LP, Mitsumoto H, Przedborski S. Amyotrophic lateral sclerosis, progressive muscular atrophy, and primary lateral sclerosis. In: Rowland LP, Pedley TA, editors. Merritt's neurology. Lippincott: Williams &amp; Wilkins; 2010. pp. 802&#x2013;808.</Citation></Reference><Reference><Citation>Mejzini R, et al. ALS genetics, mechanisms, and therapeutics: where are we now? Front Neurosci. 2019;13:1310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis S, et al. Genetics of amyotrophic lateral sclerosis: A review. J Neurol Sci. 2019;399:217&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">30870681</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HP, et al. ALS genes in the genomic era and their implications for FTD. Trends Genet. 2018;34(6):404&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Harms MM et al (1993) TARDBP-related amyotrophic lateral sclerosis. In: Adam MP (eds) GeneReviews [Internet]. University of Washington, Seattle, WA</Citation><ArticleIdList><ArticleId IdType="pubmed">20301761</ArticleId></ArticleIdList></Reference><Reference><Citation>Leblond CS, et al. Dissection of genetic factors associated with amyotrophic lateral sclerosis. Exp Neurol. 2014;262(Pt B):91&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">24780888</ArticleId></ArticleIdList></Reference><Reference><Citation>Cady J, et al. Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes. Ann Neurol. 2015;77(1):100&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4293318</ArticleId><ArticleId IdType="pubmed">25382069</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, et al. An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry. 2010;81(12):1324&#x2013;1326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2988617</ArticleId><ArticleId IdType="pubmed">20861059</ArticleId></ArticleIdList></Reference><Reference><Citation>Meltz Steinberg K, et al. Whole genome analyses reveal no pathogenetic single nucleotide or structural differences between monozygotic twins discordant for amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(5&#x2013;6):385&#x2013;392.</Citation><ArticleIdList><ArticleId IdType="pubmed">25960086</ArticleId></ArticleIdList></Reference><Reference><Citation>Camu W, et al. Conjugal amyotrophic lateral sclerosis: a report on two couples from Southern France. Neurology. 1994;44(3 Pt 1):547&#x2013;548.</Citation><ArticleIdList><ArticleId IdType="pubmed">8145930</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunnarsson LG, Bodin L. Amyotrophic lateral sclerosis and occupational exposures: a systematic literature review and meta-analyses. Int J Environ Res Public Health. 2018;15(11):2371.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6265680</ArticleId><ArticleId IdType="pubmed">30373166</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrew AS, et al. Environmental and occupational exposures and amyotrophic lateral sclerosis in New England. Neurodegener Dis. 2017;17(2&#x2013;3):110&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5383428</ArticleId><ArticleId IdType="pubmed">28122372</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters TL, et al. Blood levels of trace metals and amyotrophic lateral sclerosis. Neurotoxicology. 2016;54:119&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5451111</ArticleId><ArticleId IdType="pubmed">27085208</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero C, et al. Early life metal dysregulation in amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2020;7(6):872&#x2013;882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7318091</ArticleId><ArticleId IdType="pubmed">32438517</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang H, et al. Amyotrophic lateral sclerosis and agricultural environments: a systematic review. J Korean Med Sci. 2014;29(12):1610&#x2013;1617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4248580</ArticleId><ArticleId IdType="pubmed">25469059</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine . Amyotrophic lateral sclerosis in veterans: review of the scientific literature. Washington, DC: The National Academies Press; 2006.</Citation></Reference><Reference><Citation>Beard JD, et al. Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology. Environ Int. 2016;91:104&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4876822</ArticleId><ArticleId IdType="pubmed">26923711</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello A, et al. Retrospective assessment of occupational exposures for the GENEVA study of ALS among military veterans. Ann Work Expo Health. 2017;61(3):299&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5388189</ArticleId><ArticleId IdType="pubmed">28355414</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagiraju HKR, et al. Amyotrophic lateral sclerosis among veterans deployed in support of Post-9/11 U.S. conflicts. Mil Med. 2020;185(3&#x2013;4):e501&#x2013;e509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8921606</ArticleId><ArticleId IdType="pubmed">31642489</ArticleId></ArticleIdList></Reference><Reference><Citation>Seals RM, et al. Amyotrophic lateral sclerosis and the military: a population-based study in the Danish Registries. Epidemiology. 2016;27(2):188&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5119482</ArticleId><ArticleId IdType="pubmed">26583610</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisskopf MG, et al. Prospective study of military service and mortality from ALS. Neurology. 2005;64(1):32&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">15642900</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang F, et al. Association between blood lead and the risk of amyotrophic lateral sclerosis. Am J Epidemiol. 2010;171(10):1126&#x2013;1133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2877471</ArticleId><ArticleId IdType="pubmed">20406759</ArticleId></ArticleIdList></Reference><Reference><Citation>Mason LH, et al. Pb neurotoxicity: neuropsychological effects of lead toxicity. Biomed Res Int. 2014;2014:840547&#x2013;840547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3909981</ArticleId><ArticleId IdType="pubmed">24516855</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeliger HI. Exposure to lipophilic chemicals as a cause of neurological impairments, neurodevelopmental disorders and neurodegenerative diseases. Interdiscip Toxicol. 2013;6(3):103&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3967436</ArticleId><ArticleId IdType="pubmed">24678247</ArticleId></ArticleIdList></Reference><Reference><Citation>Birnbaum LS. The role of structure in the disposition of halogenated aromatic xenobiotics. Environ Health Perspect. 1985;61:11&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1568747</ArticleId><ArticleId IdType="pubmed">2998745</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, et al. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol. 2014;13(11):1108&#x2013;1113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4197338</ArticleId><ArticleId IdType="pubmed">25300936</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, et al. The multistep hypothesis of ALS revisited: the role of genetic mutations. Neurology. 2018;91(7):e635&#x2013;e642.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6105040</ArticleId><ArticleId IdType="pubmed">30045958</ArticleId></ArticleIdList></Reference><Reference><Citation>Horner RD, et al. Amyotrophic lateral sclerosis among 1991 Gulf War veterans: evidence for a time-limited outbreak. Neuroepidemiology. 2008;31(1):28&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">18535397</ArticleId></ArticleIdList></Reference><Reference><Citation>Horner RD, et al. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology. 2003;61(6):742&#x2013;749.</Citation><ArticleIdList><ArticleId IdType="pubmed">14504315</ArticleId></ArticleIdList></Reference><Reference><Citation>Haley RW. Excess incidence of ALS in young Gulf War veterans. Neurology. 2003;61(6):750&#x2013;756.</Citation><ArticleIdList><ArticleId IdType="pubmed">14504316</ArticleId></ArticleIdList></Reference><Reference><Citation>McKay KA, et al. Military service and related risk factors for amyotrophic lateral sclerosis. Acta Neurol Scand. 2021;143(1):39&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7756624</ArticleId><ArticleId IdType="pubmed">32905613</ArticleId></ArticleIdList></Reference><Reference><Citation>Beard JD, Kamel F. Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology and survival. Epidemiol Rev. 2015;37(1):55&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4325667</ArticleId><ArticleId IdType="pubmed">25365170</ArticleId></ArticleIdList></Reference><Reference><Citation>Department of Veterans Affairs Presumption of service connection for amyotrophic lateral sclerosis. Final rule. Federal Regist. 2009;74(212):57072&#x2013;57074.</Citation><ArticleIdList><ArticleId IdType="pubmed">20166277</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee on the Assessment of the Readjustment Needs of Military Personnel, V.T., Families Board on the Health of Select, Populations Institute of Medicine (2013) In: Returning home from Iraq and Afghanistan: assessment of readjustment needs of veterans, service members, and their families. National Academies Press, Washington, DC</Citation><ArticleIdList><ArticleId IdType="pubmed">24901192</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine . Health consequences of service during the Persian Gulf War: initial findings and recommendations for immediate action. Washington, DC: The National Academies Press; 1995.</Citation><ArticleIdList><ArticleId IdType="pubmed">25121322</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyams KC, et al. Resolving disputes about toxicological risks during military conflict: the US Gulf War experience. Toxicol Rev. 2005;24(3):167&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pubmed">16390218</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotopf M, Wessely S. Can epidemiology clear the fog of war? Lessons from the 1990&#x2013;91 Gulf War. Int J Epidemiol. 2005;34(4):791&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pubmed">15911546</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang HK, et al. Mortality among US and UK veterans of the Persian Gulf War: a review. Occup Environ Med. 2002;59(12):794&#x2013;799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1763601</ArticleId><ArticleId IdType="pubmed">12468744</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose MR, Brix KA. Neurological disorders in Gulf War veterans. Philos Trans R Soc Lond B Biol Sci. 2006;361(1468):605&#x2013;618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1569625</ArticleId><ArticleId IdType="pubmed">16687265</ArticleId></ArticleIdList></Reference><Reference><Citation>Armon C. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology. 2004;62(6):1027&#x2013;1029.</Citation><ArticleIdList><ArticleId IdType="pubmed">15037726</ArticleId></ArticleIdList></Reference><Reference><Citation>Armon C. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology. 2007;68(13):1083&#x2013;1083.</Citation><ArticleIdList><ArticleId IdType="pubmed">17389322</ArticleId></ArticleIdList></Reference><Reference><Citation>Coffman CJ, et al. Estimating the occurrence of amyotrophic lateral sclerosis among Gulf War (1990&#x2013;1991) veterans using capture-recapture methods. Neuroepidemiology. 2005;24(3):141&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">15650320</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox PA, et al. Cyanobacteria and BMAA exposure from desert dust: a possible link to sporadic ALS among Gulf War veterans. Amyotroph Lateral Scler. 2009;10(Suppl 2):109&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">19929742</ArticleId></ArticleIdList></Reference><Reference><Citation>Merwin SJ, et al. Organophosphate neurotoxicity to the voluntary motor system on the trail of environment-caused amyotrophic lateral sclerosis: the known, the misknown, and the unknown. Arch Toxicol. 2017;91(8):2939&#x2013;2952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5502199</ArticleId><ArticleId IdType="pubmed">28070599</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickerson AS, et al. Amyotrophic lateral sclerosis and exposure to diesel exhaust in a Danish cohort. Am J Epidemiol. 2018;187(8):1613&#x2013;1622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6070035</ArticleId><ArticleId IdType="pubmed">29590300</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtzke JF, Beebe GW. Epidemiology of amyotrophic lateral sclerosis: 1. A case&#x2013;control comparison based on ALS deaths. Neurology. 1980;30(5):453&#x2013;462.</Citation><ArticleIdList><ArticleId IdType="pubmed">7189251</ArticleId></ArticleIdList></Reference><Reference><Citation>Pamphlett R, Rikard-Bell A. Different occupations associated with amyotrophic lateral sclerosis: is diesel exhaust the link? PLoS ONE. 2013;8(11):e80993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3823610</ArticleId><ArticleId IdType="pubmed">24244728</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang F, et al. Workplace exposures and the risk of amyotrophic lateral sclerosis. Environ Health Perspect. 2009;117(9):1387&#x2013;1392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2737014</ArticleId><ArticleId IdType="pubmed">19750102</ArticleId></ArticleIdList></Reference><Reference><Citation>Park RM, et al. Potential occupational risks for neurodegenerative diseases. Am J Ind Med. 2005;48(1):63&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">15940722</ArticleId></ArticleIdList></Reference><Reference><Citation>IARC (1989) Diesel and gasoline engine exhausts and some nitroarenes, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, Lyon, France</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7681285</ArticleId><ArticleId IdType="pubmed">2483418</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner S, et al. Diesel exhaust: current knowledge of adverse effects and underlying cellular mechanisms. Arch Toxicol. 2016;90(7):1541&#x2013;1553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4894930</ArticleId><ArticleId IdType="pubmed">27165416</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehsanifar M, et al. Exposure to nanoscale diesel exhaust particles: oxidative stress, neuroinflammation, anxiety and depression on adult male mice. Ecotoxicol Environ Saf. 2019;168:338&#x2013;347.</Citation><ArticleIdList><ArticleId IdType="pubmed">30391838</ArticleId></ArticleIdList></Reference><Reference><Citation>Korotney D. A comprehensive analysis of biodiesel impacts on exhaust emissions. Washington, DC: Draft report of the US Environmental Protection Agency; 2002.</Citation></Reference><Reference><Citation>Chen H, et al. Living near major roads and the incidence of dementia, Parkinson&#x2019;s disease, and multiple sclerosis: a population-based cohort study. Lancet. 2017;389(10070):718&#x2013;726.</Citation><ArticleIdList><ArticleId IdType="pubmed">28063597</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi L, et al. Long-term effects of PM(2&#xb7;5) on neurological disorders in the American Medicare population: a longitudinal cohort study. Lancet Planet Health. 2020;4(12):e557&#x2013;e565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7720425</ArticleId><ArticleId IdType="pubmed">33091388</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippini T, et al. Risk of amyotrophic lateral sclerosis and exposure to particulate matter from vehicular traffic: a case&#x2013;control study. Int J Environ Res Public Health. 2021;18(3):973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7908475</ArticleId><ArticleId IdType="pubmed">33499343</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunez Y, et al. Fine particle exposure and clinical aggravation in neurodegenerative diseases in New York State. Environ Health Perspect. 2021;129(2):27003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7869948</ArticleId><ArticleId IdType="pubmed">33555200</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendtsen KM, et al. A review of health effects associated with exposure to jet engine emissions in and around airports. Environ Health. 2021;20(1):10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7866671</ArticleId><ArticleId IdType="pubmed">33549096</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholas JS, et al. Mortality among US commercial pilots and navigators. J Occup Environ Med. 1998;40(11):980&#x2013;985.</Citation><ArticleIdList><ArticleId IdType="pubmed">9830605</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendtsen KM, et al. Airport emission particles: exposure characterization and toxicity following intratracheal instillation in mice. Part Fibre Toxicol. 2019;16(1):23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6558896</ArticleId><ArticleId IdType="pubmed">31182125</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinkerton LE, et al. Mortality from neurodegenerative diseases in a cohort of US flight attendants. Am J Ind Med. 2016;59(7):532&#x2013;537.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4915549</ArticleId><ArticleId IdType="pubmed">27184412</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonner JC. Nanoparticles as a potential cause of pleural and interstitial lung disease. Proc Am Thorac Soc. 2010;7(2):138&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3266021</ArticleId><ArticleId IdType="pubmed">20427587</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu X, et al. Right or left: the role of nanoparticles in pulmonary diseases. Int J Mol Sci. 2014;15(10):17577&#x2013;17600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4227179</ArticleId><ArticleId IdType="pubmed">25268624</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsdottir HR, et al. Non-volatile particle emissions from aircraft turbine engines at ground-idle induce oxidative stress in bronchial cells. Commun Biol. 2019;2:90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6401161</ArticleId><ArticleId IdType="pubmed">30854482</ArticleId></ArticleIdList></Reference><Reference><Citation>Masiol M, Harrison RM. Aircraft engine exhaust emissions and other airport-related contributions to ambient air pollution: a review. Atmos Environ. 2014;95:409&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108289</ArticleId><ArticleId IdType="pubmed">32288558</ArticleId></ArticleIdList></Reference><Reference><Citation>Pleil JD, et al. Personal exposure to JP-8 jet fuel vapors and exhaust at air force bases. Environ Health Perspect. 2000;108(3):183&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1637984</ArticleId><ArticleId IdType="pubmed">10706522</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugh MJ, et al. Increasing prevalence of chronic lung disease in veterans of the wars in Iraq and Afghanistan. Mil Med. 2016;181(5):476&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pubmed">27136656</ArticleId></ArticleIdList></Reference><Reference><Citation>Fechter LD, et al. Subchronic JP-8 jet fuel exposure enhances vulnerability to noise-induced hearing loss in rats. J Toxicol Environ Health A. 2012;75(5):299&#x2013;317.</Citation><ArticleIdList><ArticleId IdType="pubmed">22409492</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufman LR, et al. Effects of concurrent noise and jet fuel exposure on hearing loss. J Occup Environ Med. 2005;47(3):212&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pubmed">15761316</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder&#xf3;n-Garcidue&#xf1;as L, et al. Increased gain in the auditory pathway, Alzheimer&#x2019;s Disease Continuum, and air pollution: peripheral and central auditory system dysfunction evolves across pediatric and adult urbanites. J Alzheimers Dis. 2019;70(4):1275&#x2013;1286.</Citation><ArticleIdList><ArticleId IdType="pubmed">31322574</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffith JD. Electron microscopic characterization of exhaust particles containing lead dibromide beads expelled from aircraft burning leaded gasoline. Atmos Pollut Res. 2020;11(9):1481&#x2013;1486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7583388</ArticleId><ArticleId IdType="pubmed">33100835</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin E, et al. Distinct ultrafine particle profiles associated with aircraft and roadway traffic. Environ Sci Technol. 2021;55(5):2847&#x2013;2858.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7931448</ArticleId><ArticleId IdType="pubmed">33544581</ArticleId></ArticleIdList></Reference><Reference><Citation>Pant P, Harrison RM. Estimation of the contribution of road traffic emissions to particulate matter concentrations from field measurements: a review. Atmos Environ. 2013;77:78&#x2013;97.</Citation></Reference><Reference><Citation>Amato F, et al. Concentrations, sources and geochemistry of airborne particulate matter at a major European airport. J Environ Monit. 2010;12(4):854&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pubmed">20383366</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett M, et al. Composition of smoke generated by landing aircraft. Environ Sci Technol. 2011;45(8):3533&#x2013;3538.</Citation><ArticleIdList><ArticleId IdType="pubmed">21434600</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris K (2006) An estimation of the tyre material erosion from measurements of aircraft. British Airways Environmental Affairs, British Airways Technical Documents Relating to the Aircraft Operations Supporting the Project for the Sustainable Development of Heathrow, Document 7</Citation></Reference><Reference><Citation>Consensus Study Report Long-term health consequences of exposure to burn pits in Iraq and Afghanistan. Mil Med. 2015;180(6):601&#x2013;613.</Citation><ArticleIdList><ArticleId IdType="pubmed">26032372</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharkey JM, et al. Postdeployment respiratory health care encounters following deployment to Kabul, Afghanistan: a retrospective cohort study. Mil Med. 2016;181(3):265&#x2013;271.</Citation><ArticleIdList><ArticleId IdType="pubmed">26926752</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, et al. Burn Pit emissions exposure and respiratory and cardiovascular conditions among airborne hazards and open burn pit registry participants. J Occup Environ Med. 2016;58(7):e249&#x2013;e255.</Citation><ArticleIdList><ArticleId IdType="pubmed">27218278</ArticleId></ArticleIdList></Reference><Reference><Citation>National Academies of Sciences E et al (2017) In: Butler DA et al (eds) Assessment of the Department of Veterans Affairs Airborne Hazards and Open Burn Pit Registry. National Academies Press, Washington, DC</Citation><ArticleIdList><ArticleId IdType="pubmed">28617567</ArticleId></ArticleIdList></Reference><Reference><Citation>IARC (1984) Polynuclear aromatic hydrocarbons. Part 3, Industrial exposures in aluminum production, coal gasification, coke production, and iron and steel founding. In: International Agency for Research on Cancer Monographs on the Carcinogenic Risk of Chemicals to Humans.</Citation></Reference><Reference><Citation>Miguel A, et al. On-road emissions of particulate polycyclic aromatic hydrocarbons and black carbon from gasoline and diesel vehicles. Environ Sci Technol. 1998;32(4):450&#x2013;455.</Citation></Reference><Reference><Citation>Phillips D. Polycyclic aromatic hydrocarbons in the diet. Mutation Res. 1999;443(1&#x2013;2):139&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">10415437</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen M, et al. Increased micronuclei and bulky DNA adducts in cord blood after maternal exposures to traffic-related air pollution. Environ Res. 2009;109:1012&#x2013;1020.</Citation><ArticleIdList><ArticleId IdType="pubmed">19783246</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenz DR, et al. Acrolein and other toxicant exposures in relation to cardiovascular disease among marijuana and tobacco smokers in a longitudinal cohort of HIV-positive and negative adults. EClinicalMedicine. 2021;31:100697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7846668</ArticleId><ArticleId IdType="pubmed">33554087</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonner M, et al. Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. Cancer Epidemiol Biomarkers Prev. 2005;14(1):53&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">15668476</ArticleId></ArticleIdList></Reference><Reference><Citation>Obana H, et al. Polycyclic aromatic hydrocarbons in human fat and liver. Bull Environ Contam Toxicol. 1981;27:23&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">7296033</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosone C, Shields P (1997) Molecular epidemiology of breast cancer. In: Aldaz C, et al (eds) Etiology of breast and gynecological cancers. Progress in Clinical and Biologic Research. Wiley-Liss Inc, New York, pp 93&#x2013;99</Citation></Reference><Reference><Citation>Pastor-Belda M, et al. Bioaccumulation of polycyclic aromatic hydrocarbons for forensic assessment using gas chromatography&#x2013;mass spectrometry. Chem Res Toxicol. 2019;32(8):1680&#x2013;1688.</Citation><ArticleIdList><ArticleId IdType="pubmed">31304742</ArticleId></ArticleIdList></Reference><Reference><Citation>Santodonato J. Review of the estrogenic and antiestrogenic activity of polycyclic aromatic hydrocarbons: relationship to carcinogenicity. Chemosphere. 1997;34(4):835&#x2013;848.</Citation><ArticleIdList><ArticleId IdType="pubmed">9569946</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp M, et al. Induction of the transferrin receptor gene by benzo[a]pyrene in breast cancer MCF-7 cells: potential as a biomarker of PAH exposure. Environ Mol Mutagen. 2006;47(7):518&#x2013;526.</Citation><ArticleIdList><ArticleId IdType="pubmed">16721748</ArticleId></ArticleIdList></Reference><Reference><Citation>Ralston S, et al. Stereoselective activation of dibenzo[a, l]pyrene and its trans-11,12-dihydrodiol to fjord region 11,12-diol 13,14-epoxides in a human mammary carcinoma MCF-7 cell-mediated V79 cell mutation assay. Chem Res Toxicol. 1997;10:687&#x2013;693.</Citation><ArticleIdList><ArticleId IdType="pubmed">9208176</ArticleId></ArticleIdList></Reference><Reference><Citation>Valand R, et al. Gene expression changes in rat brain regions after 7- and 28 days inhalation exposure to exhaust emissions from 1st and 2nd generation biodiesel fuels&#x2014;the FuelHealth project. Inhal Toxicol. 2018;30(7&#x2013;8):299&#x2013;312.</Citation><ArticleIdList><ArticleId IdType="pubmed">30569778</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunders CR, et al. Benzo(a)pyrene-induced acute neurotoxicity in the F-344 rat: role of oxidative stress. J Appl Toxicol. 2006;26(5):427&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pubmed">16858674</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta K, et al. A common carcinogen benzo[a]pyrene causes neuronal death in mouse via microglial activation. PLoS ONE. 2010;5(4):e9984.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2848611</ArticleId><ArticleId IdType="pubmed">20376308</ArticleId></ArticleIdList></Reference><Reference><Citation>Phani S, et al. The role of the innate immune system in ALS. Front Pharmacol. 2012;3:150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3418523</ArticleId><ArticleId IdType="pubmed">22912616</ArticleId></ArticleIdList></Reference><Reference><Citation>Das SK, et al. Chronic waterborne exposure to benzo[a]pyrene induces locomotor dysfunction and development of neurodegenerative phenotypes in zebrafish. Neurosci Lett. 2020;716:134646.</Citation><ArticleIdList><ArticleId IdType="pubmed">31796305</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohura T, et al. Polycyclic aromatic hydrocarbons in indoor and outdoor environments and factors affecting their concentrations. Environ Sci Technol. 2004;38(1):77&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">14740720</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamel F, et al. Pesticide exposure and amyotrophic lateral sclerosis. Neurotoxicology. 2012;33(3):457&#x2013;462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3358481</ArticleId><ArticleId IdType="pubmed">22521219</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman SA, et al. High plasma concentrations of organic pollutants negatively impact survival in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2019;90(8):907&#x2013;912.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6625908</ArticleId><ArticleId IdType="pubmed">30760645</ArticleId></ArticleIdList></Reference><Reference><Citation>Srogi K. Levels and congener distributions of PCDDs, PCDFs and dioxin-like PCBs in environmental and human samples: a review. Environ Chem Lett. 2008;6(1):1&#x2013;28.</Citation></Reference><Reference><Citation>Ness DK, et al. PCB congeners in the rat brain: selective accumulation and lack of regionalization. J Toxicol Environ Health. 1994;43(4):453&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pubmed">7990170</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberman DA, et al. Sex-specific effects of developmental exposure to polychlorinated biphenyls on neuroimmune and dopaminergic endpoints in adolescent rats. Neurotoxicol Teratol. 2020;79:106880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7340239</ArticleId><ArticleId IdType="pubmed">32259577</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell MR, et al. Sex differences in effects of gestational polychlorinated biphenyl exposure on hypothalamic neuroimmune and neuromodulator systems in neonatal rats. Toxicol Appl Pharmacol. 2018;353:55&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7846971</ArticleId><ArticleId IdType="pubmed">29879404</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjaly ZR, et al. The sex ratio in amyotrophic lateral sclerosis: a population based study. Amyotroph Lateral Scler. 2010;11(5):439&#x2013;442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6485484</ArticleId><ArticleId IdType="pubmed">20225930</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouchard MF, et al. Polychlorinated biphenyl exposures and cognition in older US adults: NHANES (1999&#x2013;2002) Environ Health Perspect. 2014;122(1):73&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3888566</ArticleId><ArticleId IdType="pubmed">24275543</ArticleId></ArticleIdList></Reference><Reference><Citation>Su FC, et al. Association of environmental toxins with amyotrophic lateral sclerosis. JAMA Neurol. 2016;73(7):803&#x2013;811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5032145</ArticleId><ArticleId IdType="pubmed">27159543</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruder AM, et al. Mortality among 24,865 workers exposed to polychlorinated biphenyls (PCBs) in three electrical capacitor manufacturing plants: a ten-year update. Int J Hyg Environ Health. 2014;217(2&#x2013;3):176&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4557692</ArticleId><ArticleId IdType="pubmed">23707056</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatcher JM, et al. Parkinson's disease and pesticides: a toxicological perspective. Trends Pharmacol Sci. 2008;29(6):322&#x2013;329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5683846</ArticleId><ArticleId IdType="pubmed">18453001</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisskopf MG, et al. Persistent organochlorine pesticides in serum and risk of Parkinson disease. Neurology. 2010;74(13):1055&#x2013;1061.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2848105</ArticleId><ArticleId IdType="pubmed">20350979</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes SL, et al. Pesticides that inhibit the ubiquitin-proteasome system: effect measure modification by genetic variation in SKP1 in Parkinson&#x2019;s disease. Environ Res. 2013;126:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3832349</ArticleId><ArticleId IdType="pubmed">23988235</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenland K, et al. Occupational pesticide exposure and screening tests for neurodegenerative disease among an elderly population in Costa Rica. Environ Res. 2013;120:96&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">23092715</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson JR, et al. Elevated serum pesticide levels and risk of Parkinson disease. Arch Neurol. 2009;66(7):870&#x2013;875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3383784</ArticleId><ArticleId IdType="pubmed">19597089</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson JR, et al. &#x3b2;-Hexachlorocyclohexane levels in serum and risk of Parkinson&#x2019;s disease. Neurotoxicology. 2011;32(5):640&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3176949</ArticleId><ArticleId IdType="pubmed">21620887</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrigan FM, et al. Organochlorine compounds in human brain. Hum Exp Toxicol. 1996;15(3):262&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">8839217</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrigan FM, et al. Organochlorine insecticides in substantia nigra in Parkinson&#x2019;s disease. J Toxicol Environ Health A. 2000;59(4):229&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pubmed">10706031</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatcher JM, et al. Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system. Exp Neurol. 2007;204(2):619&#x2013;630.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1896133</ArticleId><ArticleId IdType="pubmed">17291500</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatcher JM, et al. Disruption of dopamine transport by DDT and its metabolites. Neurotoxicology. 2008;29(4):682&#x2013;690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4755343</ArticleId><ArticleId IdType="pubmed">18533268</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellou E, et al. Polygenic risk and pleiotropy in neurodegenerative diseases. Neurobiol Dis. 2020;142:104953.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7378564</ArticleId><ArticleId IdType="pubmed">32445791</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang SY, et al. The role of gene variants in the pathogenesis of neurodegenerative disorders as revealed by next generation sequencing studies: a review. Transl Neurodegener. 2017;6:27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5639582</ArticleId><ArticleId IdType="pubmed">29046784</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley WG, et al. Gene&#x2013;environment&#x2013;-time interactions in neurodegenerative diseases: hypotheses and research approaches. Ann Neurosci. 2018;25(4):261&#x2013;267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6470336</ArticleId><ArticleId IdType="pubmed">31000966</ArticleId></ArticleIdList></Reference><Reference><Citation>Nghi TN, et al. Dioxins and Nonortho PCBs in breast milk of vietnamese mothers living in the largest hot spot of dioxin contamination. Environ Sci Technol. 2015;49(9):5732&#x2013;5742.</Citation><ArticleIdList><ArticleId IdType="pubmed">25798921</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan K, et al. Wartime toxin exposure: recognising the silent killer. BMJ Case Rep. 2016 doi: 10.1136/bcr-2016-217438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2016-217438</ArticleId><ArticleId IdType="pmc">PMC5174831</ArticleId><ArticleId IdType="pubmed">27908921</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey KM, et al. Establishing a role for environmental toxicant exposure induced epigenetic remodeling in malignant transformation. Semin Cancer Biol. 2019;57:86&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6522338</ArticleId><ArticleId IdType="pubmed">30453042</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill A, et al. Neurodevelopmental defects in zebrafish (Danio rerio) at environmentally relevant dioxin (TCDD) concentrations. Toxicol Sci. 2003;76(2):392&#x2013;399.</Citation><ArticleIdList><ArticleId IdType="pubmed">14600291</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu G, et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced inflammatory activation is mediated by intracellular free calcium in microglial cells. Toxicology. 2013;308:158&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pubmed">23583884</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie HQ, et al. AhR-mediated effects of dioxin on neuronal acetylcholinesterase expression in vitro. Environ Health Perspect. 2013;121(5):613&#x2013;618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3673198</ArticleId><ArticleId IdType="pubmed">23426015</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Pino Sans J, et al. Developmental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin may alter LH release patterns by abolishing sex differences in GABA/glutamate cell number and modifying the transcriptome of the male anteroventral periventricular nucleus. Neuroscience. 2016;329:239&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">27185484</ArticleId></ArticleIdList></Reference><Reference><Citation>Gohlke JM, et al. AhR-mediated gene expression in the developing mouse telencephalon. Reprod Toxicol. 2009;28(3):321&#x2013;328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2766425</ArticleId><ArticleId IdType="pubmed">19465110</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura E, et al. In utero and lactational dioxin exposure induces Sema3b and Sema3g gene expression in the developing mouse brain. Biochem Biophys Res Commun. 2016;476(2):108&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pubmed">27178212</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces microglial nitric oxide production and subsequent rat primary cortical neuron apoptosis through p38/JNK MAPK pathway. Toxicology. 2013;312:132&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pubmed">23969120</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu G, et al. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces expression of p27(kip1) and FoxO3a in female rat cerebral cortex and PC12 cells. Toxicol Lett. 2014;226(3):294&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">24594276</ArticleId></ArticleIdList></Reference><Reference><Citation>Amenya HZ, et al. Dioxin induces Ahr-dependent robust DNA demethylation of the Cyp1a1 promoter via Tdg in the mouse liver. Sci Rep. 2016;6:34989.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5054525</ArticleId><ArticleId IdType="pubmed">27713569</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash PEA, et al. Dioxins and related environmental contaminants increase TDP-43 levels. Mol Neurodegener. 2017;12(1):35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5420162</ArticleId><ArticleId IdType="pubmed">28476168</ArticleId></ArticleIdList></Reference><Reference><Citation>Karri V, et al. Differential protein expression of hippocampal cells associated with heavy metals (Pb, As, and MeHg) neurotoxicity: deepening into the molecular mechanism of neurodegenerative diseases. J Proteomics. 2018;187:106&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pubmed">30017948</ArticleId></ArticleIdList></Reference><Reference><Citation>De Benedetti S, et al. Blood trace metals in a sporadic amyotrophic lateral sclerosis geographical cluster. Biometals. 2017;30(3):355&#x2013;365.</Citation><ArticleIdList><ArticleId IdType="pubmed">28337565</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos PM, et al. Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis. Biol Trace Elem Res. 2013;151(2):159&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">23225075</ArticleId></ArticleIdList></Reference><Reference><Citation>Callaghan B, et al. The association of exposure to lead, mercury, and selenium and the development of amyotrophic lateral sclerosis and the epigenetic implications. Neurodegener Dis. 2011;8(1&#x2013;2):1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20689252</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojsi F, et al. Exposure to environmental toxicants and pathogenesis of amyotrophic lateral sclerosis: state of the art and research perspectives. Int J Mol Sci. 2013;14(8):15286&#x2013;15311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3759860</ArticleId><ArticleId IdType="pubmed">23887652</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicero CE, et al. Metals and neurodegenerative diseases. A systematic review. Environ Res. 2017;159:82&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">28777965</ArticleId></ArticleIdList></Reference><Reference><Citation>Oggiano R, et al. Trace elements in ALS patients and their relationships with clinical severity. Chemosphere. 2018;197:457&#x2013;466.</Citation><ArticleIdList><ArticleId IdType="pubmed">29366958</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrew AS, et al. Toenail mercury levels are associated with amyotrophic lateral sclerosis risk. Muscle Nerve. 2018 doi: 10.1002/mus.26055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26055</ArticleId><ArticleId IdType="pmc">PMC6034986</ArticleId><ArticleId IdType="pubmed">29314106</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrew AS, et al. Keratinous biomarker of mercury exposure associated with amyotrophic lateral sclerosis risk in a nationwide U.S. study. Amyotroph Lateral Scler Frontotemporal. 2020;21:421&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7483924</ArticleId><ArticleId IdType="pubmed">32329357</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrew AS, et al. Risk factors for amyotrophic lateral sclerosis: a regional United States case&#x2013;control study. Muscle Nerve. 2021;63(1):52&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7821307</ArticleId><ArticleId IdType="pubmed">33006184</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamel F, et al. Lead exposure as a risk factor for amyotrophic lateral sclerosis. Neurodegener Dis. 2005;2(3&#x2013;4):195&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">16909025</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingre C, et al. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7:181&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4334292</ArticleId><ArticleId IdType="pubmed">25709501</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang MD, et al. Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. Neurotoxicology. 2017;61:101&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pubmed">27377857</ArticleId></ArticleIdList></Reference><Reference><Citation>Belbasis L, et al. Environmental risk factors and amyotrophic lateral sclerosis: an umbrella review and critical assessment of current evidence from systematic reviews and meta-analyses of observational studies. Neuroepidemiology. 2016;46(2):96&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">26731747</ArticleId></ArticleIdList></Reference><Reference><Citation>Neal AP, Guilarte TR. Mechanisms of lead and manganese neurotoxicity. Toxicol Res (Camb) 2013;2(2):99&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4338437</ArticleId><ArticleId IdType="pubmed">25722848</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash PEA, et al. Heavy metal neurotoxicants induce ALS-linked TDP-43 pathology. Toxicol Sci. 2019;167(1):105&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6317426</ArticleId><ArticleId IdType="pubmed">30371865</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasperczyk S, et al. The effect of occupational lead exposure on lipid peroxidation, protein carbonylation, and plasma viscosity. Toxicol Ind Health. 2015;31(12):1165&#x2013;1171.</Citation><ArticleIdList><ArticleId IdType="pubmed">23709227</ArticleId></ArticleIdList></Reference><Reference><Citation>Laidlaw MAS, et al. Lead exposure at firing ranges&#x2014;a review. Environ Health. 2017;16(1):34&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5379568</ArticleId><ArticleId IdType="pubmed">28376827</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickerson AS, et al. Population-based study of amyotrophic lateral sclerosis and occupational lead exposure in Denmark. Occup Environ Med. 2019;76(4):208&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6433465</ArticleId><ArticleId IdType="pubmed">30705111</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahran S, et al. Motor neuron disease mortality and lifetime petrol lead exposure: evidence from national age-specific and state-level age-standardized death rates in Australia. Environ Res. 2017;153:181&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">27992849</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare SS, et al. Trace element imbalances in amyotrophic lateral sclerosis. Neurotoxicology. 1990;11(3):521&#x2013;532.</Citation><ArticleIdList><ArticleId IdType="pubmed">2284056</ArticleId></ArticleIdList></Reference><Reference><Citation>Zufir&#xed;a M, et al. ALS: A bucket of genes, environment, metabolism and unknown ingredients. Prog Neurobiol. 2016;142:104&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pubmed">27236050</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams CR, et al. Mercury intoxication simulating amyotrophic lateral sclerosis. JAMA. 1983;250(5):642&#x2013;643.</Citation><ArticleIdList><ArticleId IdType="pubmed">6864963</ArticleId></ArticleIdList></Reference><Reference><Citation>Praline J, et al. ALS and mercury intoxication: a relationship? Clin Neurol Neurosurg. 2007;109(10):880&#x2013;883.</Citation><ArticleIdList><ArticleId IdType="pubmed">17719172</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangelsdorf I, et al. Healing of amyotrophic lateral sclerosis: a case report. Complement Med Res. 2017;24(3):175&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pubmed">28641283</ArticleId></ArticleIdList></Reference><Reference><Citation>Arvidson B. Accumulation of inorganic mercury in lower motoneurons of mice. Neurotoxicology. 1992;13(1):277&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">1508431</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuu J-J, et al. Differential neurotoxic effects of methylmercury and mercuric sulfide in rats. Toxicol Lett. 2007;169(2):109&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pubmed">17292570</ArticleId></ArticleIdList></Reference><Reference><Citation>Farina M, et al. Mechanisms of methylmercury-induced neurotoxicity: evidence from experimental studies. Life Sci. 2011;89(15&#x2013;16):555&#x2013;563.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3183295</ArticleId><ArticleId IdType="pubmed">21683713</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell JD, et al. Trace elements in the spinal cord and other tissues in motor neuron disease. J Neurol Neurosurg Psychiatry. 1986;49(2):211&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1028692</ArticleId><ArticleId IdType="pubmed">3950642</ArticleId></ArticleIdList></Reference><Reference><Citation>Estevez AO, et al. Selenium induces cholinergic motor neuron degeneration in Caenorhabditis elegans. Neurotoxicology. 2012;33(5):1021&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3445719</ArticleId><ArticleId IdType="pubmed">22560997</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M, et al. Are environmental exposures to selenium, heavy metals, and pesticides risk factors for amyotrophic lateral sclerosis? Rev Environ Health. 2012;27(1):19&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">22755265</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M, et al. Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite. Neurotoxicology. 2013;38:25&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3770807</ArticleId><ArticleId IdType="pubmed">23732511</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilen B, et al. Examination of metal mobilization from a gunshot by scanning acoustic microscopy, scanning electron microscopy, energy-dispersive X-ray spectroscopy, and inductively coupled plasma optical emission spectroscopy: a case report. J Med Case Reports. 2018;12(1):391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6310982</ArticleId><ArticleId IdType="pubmed">30593288</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilness AW, Hichberg FH. Amyotrophic lateral sclerosis in a high selenium environment. JAMA. 1977;237(26):2843&#x2013;2844.</Citation><ArticleIdList><ArticleId IdType="pubmed">577250</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M, et al. Amyotrophic lateral sclerosis after long-term exposure to drinking water with high selenium content. Epidemiology. 1996;7(5):529&#x2013;532.</Citation><ArticleIdList><ArticleId IdType="pubmed">8862986</ArticleId></ArticleIdList></Reference><Reference><Citation>Markesbery WR, et al. Neutron activation analysis of trace elements in motor neuron disease spinal cord. Neurodegeneration. 1995;4(4):383&#x2013;390.</Citation><ArticleIdList><ArticleId IdType="pubmed">8846231</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriwaka F, et al. Mercury and selenium contents in amyotrophic lateral sclerosis in Hokkaido, the northernmost island of Japan. J Neurol Sci. 1993;118(1):38&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">8229049</ArticleId></ArticleIdList></Reference><Reference><Citation>Gribble MO, et al. Mercury, selenium and fish oils in marine food webs and implications for human health. J Mar Biol Assoc U K. 2016;96(1):43&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4720108</ArticleId><ArticleId IdType="pubmed">26834292</ArticleId></ArticleIdList></Reference><Reference><Citation>Ralston NV. Selenium health benefit values as seafood safety criteria. EcoHealth. 2008;5(4):442&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pubmed">19365692</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergomi M, et al. Environmental exposure to trace elements and risk of amyotrophic lateral sclerosis: a population-based case&#x2013;control study. Environ Res. 2002;89(2):116&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pubmed">12123644</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang TN, et al. Increased metal content in the TDP-43(A315T) transgenic mouse model of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Front Aging Neurosci. 2014;6:15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3920072</ArticleId><ArticleId IdType="pubmed">24575040</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovejoy DB, Guillemin GJ. The potential for transition metal-mediated neurodegeneration in amyotrophic lateral sclerosis. Front Aging Neurosci. 2014;6:173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4107949</ArticleId><ArticleId IdType="pubmed">25100994</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi BS, Zheng W. Copper transport to the brain by the blood&#x2013;brain barrier and blood-CSF barrier. Brain Res. 2009;1248:14&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2677986</ArticleId><ArticleId IdType="pubmed">19014916</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilarte TR. Manganese and Parkinson's disease: a critical review and new findings. Environ Health Perspect. 2010;118(8):1071&#x2013;1080.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2920085</ArticleId><ArticleId IdType="pubmed">20403794</ArticleId></ArticleIdList></Reference><Reference><Citation>Wi&#x15b;niewska-Hejka Z, et al. Neurological examinations of workers with chronic exposure to manganese dioxide during the production of piles and batteries. Neurol Neurochir Pol. 1978;12(4):435&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pubmed">213738</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss H. Progressive bulbar paralysis and amyotrophie lateral sclerosis following chronic manganese poisoning. Arch Gewerbepath Gewerbehyg. 1939;9:464&#x2013;476.</Citation></Reference><Reference><Citation>Yanagihara R. Heavy metals and essential minerals in motor neuron disease. Adv Neurol. 1982;36:233&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pubmed">7180685</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyata S, et al. Increased manganese level in spinal cords of amyotrophic lateral sclerosis determined by radiochemical neutron activation analysis. J Neurol Sci. 1983;61(2):283&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pubmed">6644329</ArticleId></ArticleIdList></Reference><Reference><Citation>Hozumi I, et al. Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J Neurol Sci. 2011;303(1&#x2013;2):95&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">21292280</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos PM, et al. Manganese in cerebrospinal fluid and blood plasma of patients with amyotrophic lateral sclerosis. Exp Biol Med (Maywood) 2012;237(7):803&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pubmed">22859739</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasarskis EJ, et al. Aluminum, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy: a preliminary study. J Neurol Sci. 1995;130(2):203&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">8586987</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong SY, et al. Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis. J Neurosci. 2009;29(3):610&#x2013;619.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6665152</ArticleId><ArticleId IdType="pubmed">19158288</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan JY, et al. Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology. PLoS ONE. 2012;7(4):e35241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3328441</ArticleId><ArticleId IdType="pubmed">22529995</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, et al. Prevention of motor neuron degeneration by novel iron chelators in SOD1(G93A) transgenic mice of amyotrophic lateral sclerosis. Neurodegener Dis. 2011;8(5):310&#x2013;321.</Citation><ArticleIdList><ArticleId IdType="pubmed">21346313</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahidnia A, et al. Arsenic neurotoxicity&#x2014;a review. Hum Exp Toxicol. 2007;26(10):823&#x2013;832.</Citation><ArticleIdList><ArticleId IdType="pubmed">18025055</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazumdar S, et al. Arsenicosis: unusual neurological presentation from West Bengal. J Assoc Physicians India. 2010;58:201&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">20853535</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyler CR, Allan AM. The effects of arsenic exposure on neurological and cognitive dysfunction in human and rodent studies: a review. Curr Environ Health Rep. 2014;1(2):132&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4026128</ArticleId><ArticleId IdType="pubmed">24860722</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubey M, Shea TB. Potentiation of arsenic neurotoxicity by folate deprivation: protective role of S-adenosyl methionine. Nutr Neurosci. 2007;10(5&#x2013;6):199&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">18284027</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh CW, et al. Chronic oxidative stress promotes GADD34-mediated phosphorylation of the TAR DNA-binding protein TDP-43, a modification linked to neurodegeneration. J Biol Chem. 2018;293(1):163&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5766914</ArticleId><ArticleId IdType="pubmed">29109149</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiw WJ, et al. Aluminum in neurological disease&#x2014;a 36 year multicenter study. J Alzheimers Dis Parkinsonism. 2019;8(6):457.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6550484</ArticleId><ArticleId IdType="pubmed">31179161</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanias GD, Kapaki E. Trace elements, age, and sex in amyotrophic lateral sclerosis disease. Biol Trace Elem Res. 1997;56(2):187&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">9164664</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapaki E, et al. Zinc, copper and magnesium concentration in serum and CSF of patients with neurological disorders. Acta Neurol Scand. 1989;79(5):373&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pubmed">2545071</ArticleId></ArticleIdList></Reference><Reference><Citation>Bar-Sela S, et al. Amyotrophic lateral sclerosis in a battery-factory worker exposed to cadmium. Int J Occup Environ Health. 2001;7(2):109&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">11373040</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M, et al. Lead, cadmium and mercury in cerebrospinal fluid and risk of amyotrophic lateral sclerosis: a case&#x2013;control study. J Trace Elem Med Biol. 2017;43:121&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5495626</ArticleId><ArticleId IdType="pubmed">28089071</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickerson AS, et al. Study of occupational chromium, iron, and nickel exposure and amyotrophic lateral sclerosis in Denmark. Int J Environ Res Public Health. 2020;17(21):8086.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7663552</ArticleId><ArticleId IdType="pubmed">33147887</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourke CA. Molybdenum deficiency produces motor nervous effects that are consistent with amyotrophic lateral sclerosis. Front Neurol. 2016;7:28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4782119</ArticleId><ArticleId IdType="pubmed">27014182</ArticleId></ArticleIdList></Reference><Reference><Citation>Grochowski C, et al. Analysis of trace elements in human brain: its aim, methods, and concentration levels. Front Chem. 2019;7:115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6411644</ArticleId><ArticleId IdType="pubmed">30891444</ArticleId></ArticleIdList></Reference><Reference><Citation>Gellein K, et al. Concentrations of Cd Co, Cu, Fe, Mn, Rb, V, and Zn in formalin-fixed brain tissue in amyotrophic lateral sclerosis and Parkinsonism-dementia complex of Guam determined by High-resolution ICP-MS. Biol Trace Elem Res. 2003;96(1&#x2013;3):39&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">14716085</ArticleId></ArticleIdList></Reference><Reference><Citation>Huat TJ, et al. Metal toxicity links to Alzheimer's disease and neuroinflammation. J Mol Biol. 2019;431(9):1843&#x2013;1868.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6475603</ArticleId><ArticleId IdType="pubmed">30664867</ArticleId></ArticleIdList></Reference><Reference><Citation>Waterman SJ, et al. Lead alters the immunogenicity of two neural proteins: a potential mechanism for the progression of lead-induced neurotoxicity. Environ Health Perspect. 1994;102(12):1052&#x2013;1056.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1567485</ArticleId><ArticleId IdType="pubmed">7536156</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawa Y, Yamada S. A novel hypothesis on metal dyshomeostasis and mitochondrial dysfunction in amyotrophic lateral sclerosis: potential pathogenetic mechanism and therapeutic implications. Eur J Pharmacol. 2021;892:173737.</Citation><ArticleIdList><ArticleId IdType="pubmed">33220280</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjidemetriou M, Kostarelos K. Nanomedicine: evolution of the nanoparticle corona. Nat Nanotechnol. 2017;12(4):288&#x2013;290.</Citation><ArticleIdList><ArticleId IdType="pubmed">28383044</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedervall T, et al. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA. 2007;104(7):2050&#x2013;2055.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1892985</ArticleId><ArticleId IdType="pubmed">17267609</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang L, et al. Engineered nanoparticles interacting with cells: size matters. J Nanobiotechnology. 2014;12:5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3922601</ArticleId><ArticleId IdType="pubmed">24491160</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawicki K, et al. Toxicity of metallic nanoparticles in the central nervous system. Nanotechnol Rev. 2019;8(1):175&#x2013;200.</Citation></Reference><Reference><Citation>Salvati A, et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol. 2013;8(2):137&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pubmed">23334168</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatoo MA, et al. Physicochemical properties of nanomaterials: implication in associated toxic manifestations. BioMed Res Int. 2014 doi: 10.1155/2014/498420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/498420</ArticleId><ArticleId IdType="pmc">PMC4140132</ArticleId><ArticleId IdType="pubmed">25165707</ArticleId></ArticleIdList></Reference><Reference><Citation>Aillon KL, et al. Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv Drug Deliv Rev. 2009;61(6):457&#x2013;466.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2743376</ArticleId><ArticleId IdType="pubmed">19386275</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Schluesener HJ. Nanosilver: a nanoproduct in medical application. Toxicol Lett. 2008;176(1):1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">18022772</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed M, et al. Silver nanoparticle applications and human health. Clin Chim Acta. 2010;411(23&#x2013;24):1841&#x2013;1848.</Citation><ArticleIdList><ArticleId IdType="pubmed">20719239</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh AK. Engineered nanoparticles: structure, properties and mechanisms of toxicity. New York: Academic Press; 2015.</Citation></Reference><Reference><Citation>Khan I, et al. Nanoparticles: properties, applications and toxicities. Arab J Chem. 2019;12(7):908&#x2013;931.</Citation></Reference><Reference><Citation>Zhang XQ, et al. Interactions of nanomaterials and biological systems: implications to personalized nanomedicine. Adv Drug Deliv Rev. 2012;64(13):1363&#x2013;1384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3517211</ArticleId><ArticleId IdType="pubmed">22917779</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeevanandam J, et al. Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations. Beilstein J Nanotechnol. 2018;9:1050&#x2013;1074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5905289</ArticleId><ArticleId IdType="pubmed">29719757</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundschuh M, et al. Nanoparticles in the environment: where do we come from, where do we go to? Environ Sci Eur. 2018;30(1):6&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5803285</ArticleId><ArticleId IdType="pubmed">29456907</ArticleId></ArticleIdList></Reference><Reference><Citation>Teleanu DM, et al. Impact of nanoparticles on brain health: an up to date overview. J Clin Med. 2018;7(12):490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6306759</ArticleId><ArticleId IdType="pubmed">30486404</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder&#xf3;n-Garcidue&#xf1;as L, et al. Quadruple abnormal protein aggregates in brainstem pathology and exogenous metal-rich magnetic nanoparticles. The substantia nigrae is a very early target in young urbanites and the gastrointestinal tract likely a key brainstem portal. Environ Res. 2020;191:110139.</Citation><ArticleIdList><ArticleId IdType="pubmed">32888951</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberd&#xf6;rster G, et al. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol. 2004;16(6&#x2013;7):437&#x2013;445.</Citation><ArticleIdList><ArticleId IdType="pubmed">15204759</ArticleId></ArticleIdList></Reference><Reference><Citation>Fr&#xf6;hlich E, Salar-Behzadi S. Toxicological assessment of inhaled nanoparticles: role of in vivo, ex vivo, in vitro, and in silico studies. Int J Mol Sci. 2014;15(3):4795&#x2013;4822.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3975425</ArticleId><ArticleId IdType="pubmed">24646916</ArticleId></ArticleIdList></Reference><Reference><Citation>De Matteis V. Exposure to inorganic nanoparticles: routes of entry, immune response, biodistribution and in vitro/in vivo toxicity evaluation. Toxics. 2017;5(4):29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5750557</ArticleId><ArticleId IdType="pubmed">29051461</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao H. Progress and perspectives on targeting nanoparticles for brain drug delivery. Acta Pharm Sin B. 2016;6(4):268&#x2013;286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4951594</ArticleId><ArticleId IdType="pubmed">27471668</ArticleId></ArticleIdList></Reference><Reference><Citation>Busquets MA, et al. Magnetic nanoparticles cross the blood-brain barrier: when physics rises to a challenge. Nanomaterials (Basel) 2015;5(4):2231&#x2013;2248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5304810</ArticleId><ArticleId IdType="pubmed">28347118</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, et al. Crossing the blood&#x2013;brain barrier with nanoparticles. J Control Release. 2018;270:290&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pubmed">29269142</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardo SM, et al. Key for crossing the BBB with nanoparticles: the rational design. Beilstein J Nanotechnol. 2020;11:866&#x2013;883.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7277618</ArticleId><ArticleId IdType="pubmed">32551212</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia GJM, et al. Olfactory deposition of inhaled nanoparticles in humans. Inhalation Toxicol. 2015;27(8):394&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4745908</ArticleId><ArticleId IdType="pubmed">26194036</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardeshi CV, Belgamwar VS. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood&#x2013;brain barrier: an excellent platform for brain targeting. Expert Opin Drug Deliv. 2013;10(7):957&#x2013;972.</Citation><ArticleIdList><ArticleId IdType="pubmed">23586809</ArticleId></ArticleIdList></Reference><Reference><Citation>Elder A, et al. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect. 2006;114(8):1172&#x2013;1178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1552007</ArticleId><ArticleId IdType="pubmed">16882521</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutunkova M, et al. Toxic effects of low-level long-term inhalation exposures of rats to nickel oxide nanoparticles. Int J Mol Sci. 2019;20:1778.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6479379</ArticleId><ArticleId IdType="pubmed">30974874</ArticleId></ArticleIdList></Reference><Reference><Citation>Riediker M, et al. Particle toxicology and health&#x2014;where are we? Part Fibre Toxicol. 2019;16(1):19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6480662</ArticleId><ArticleId IdType="pubmed">31014371</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewinski N, et al. Cytotoxicity of nanoparticles. Small. 2008;4(1):26&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">18165959</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoroddu MA, et al. Toxicity of nanoparticles. Curr Med Chem. 2014;21(33):3837&#x2013;3853.</Citation><ArticleIdList><ArticleId IdType="pubmed">25306903</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Ju D. Neurotoxicity of nanomaterials and nanomedicine. New York: Academic Press; 2017.</Citation></Reference><Reference><Citation>Kumar V et al (2018) Chapter 17&#x2014;impact of nanoparticles on oxidative stress and responsive antioxidative defense in plants. In: Tripathi DK et al (eds) Nanomaterials in plants, algae, and microorganisms. Academic Press, New York, pp 393&#x2013;406</Citation></Reference><Reference><Citation>Zuberek M, Grzelak A. Nanoparticles-caused oxidative imbalance. Adv Exp Med Biol. 2018;1048:85&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">29453534</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauricio MD, et al. Nanoparticles in medicine: a focus on vascular oxidative stress. Oxid Med Cell Longev. 2018;2018:6231482&#x2013;6231482.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6178176</ArticleId><ArticleId IdType="pubmed">30356429</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganguly R et al (2019) Chapter 3&#x2014;nanoparticles as modulators of oxidative stress. In: Maurya PK, Singh S (eds) Nanotechnology in modern animal biotechnology. Elsevier, Amsterdam, pp 29&#x2013;35</Citation></Reference><Reference><Citation>Lovisolo D, et al. Nanoparticles and potential neurotoxicity: focus on molecular mechanisms. AIMS Mol Sci. 2018;5:1&#x2013;13.</Citation></Reference><Reference><Citation>Grissa I, et al. The effect of titanium dioxide nanoparticles on neuroinflammation response in rat brain. Environ Sci Pollut Res Int. 2016;23(20):20205&#x2013;20213.</Citation><ArticleIdList><ArticleId IdType="pubmed">27443856</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B-G, et al. Effects of nanoparticles on neuroinflammation in a mouse model of asthma. Respir Physiol Neurobiol. 2020;271:103292.</Citation><ArticleIdList><ArticleId IdType="pubmed">31542455</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang H, et al. Neuroinflammation is induced by tongue-instilled ZnO nanoparticles via the Ca2+-dependent NF-&#x3ba;B and MAPK pathways. Part Fibre Toxicol. 2018;15(1):39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6194560</ArticleId><ArticleId IdType="pubmed">30340606</ArticleId></ArticleIdList></Reference><Reference><Citation>Manickam V, et al. Iron oxide nanoparticles induces cell cycle-dependent neuronal apoptosis in mice. J Mol Neurosci. 2018;64(3):352&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pubmed">29368134</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng L, et al. Mechanisms of TiO2 nanoparticle-induced neuronal apoptosis in rat primary cultured hippocampal neurons. J Biomed Mater Res A. 2015;103(3):1141&#x2013;1149.</Citation><ArticleIdList><ArticleId IdType="pubmed">25045142</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebda MA, et al. Potential role of &#x3b1;-lipoic acid and Ginkgo biloba against silver nanoparticles-induced neuronal apoptosis and blood-brain barrier impairments in rats. Life Sci. 2018;212:251&#x2013;260.</Citation><ArticleIdList><ArticleId IdType="pubmed">30304694</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue Y, et al. Four types of inorganic nanoparticles stimulate the inflammatory reaction in brain microglia and damage neurons in vitro. Toxicol Lett. 2012;214(2):91&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">22939914</ArticleId></ArticleIdList></Reference><Reference><Citation>Imam SZ, et al. Iron oxide nanoparticles induce dopaminergic damage: in vitro pathways and in vivo imaging reveals mechanism of neuronal damage. Mol Neurobiol. 2015;52(2):913&#x2013;926.</Citation><ArticleIdList><ArticleId IdType="pubmed">26099304</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsaesser A, Howard CV. Toxicology of nanoparticles. Adv Drug Deliv Rev. 2012;64(2):129&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">21925220</ArticleId></ArticleIdList></Reference><Reference><Citation>Trickler WJ, et al. Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells. Toxicol Sci. 2010;118(1):160&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">20713472</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase A, et al. Effects of silver nanoparticles on primary mixed neural cell cultures: uptake, oxidative stress and acute calcium responses. Toxicol Sci. 2012;126(2):457&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3307608</ArticleId><ArticleId IdType="pubmed">22240980</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder&#xf3;n-Garcidue&#xf1;as L, et al. Alzheimer disease starts in childhood in polluted Metropolitan Mexico City. A major health crisis in progress. Environ Res. 2020;183:109137.</Citation><ArticleIdList><ArticleId IdType="pubmed">32006765</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder&#xf3;n-Garcidue&#xf1;as L, et al. Combustion and friction-derived nanoparticles and industrial-sourced nanoparticles: the culprit of Alzheimer and Parkinson's diseases. Environ Res. 2019;176:108574.</Citation><ArticleIdList><ArticleId IdType="pubmed">31299618</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins LE, et al. Repeated iron-soot exposure and nose-to-brain transport of inhaled ultrafine particles. Toxicol Pathol. 2018;46(1):75&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6405220</ArticleId><ArticleId IdType="pubmed">28914166</ArticleId></ArticleIdList></Reference><Reference><Citation>Maher BA, et al. Magnetite pollution nanoparticles in the human brain. Proc Natl Acad Sci USA. 2016;113(39):10797&#x2013;10801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5047173</ArticleId><ArticleId IdType="pubmed">27601646</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdiglesias V, et al. Are iron oxide nanoparticles safe? Current knowledge and future perspectives. J Trace Elem Med Biol. 2016;38:53&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">27056797</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellani RJ, et al. Iron: the Redox-active center of oxidative stress in Alzheimer disease. Neurochem Res. 2007;32(10):1640&#x2013;1645.</Citation><ArticleIdList><ArticleId IdType="pubmed">17508283</ArticleId></ArticleIdList></Reference><Reference><Citation>Coccini T, et al. Cytotoxicity and proliferative capacity impairment induced on human brain cell cultures after short-and long-term exposure to magnetite nanoparticles. J Appl Toxicol. 2017;37(3):361&#x2013;373.</Citation><ArticleIdList><ArticleId IdType="pubmed">27480414</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarjanli Z, et al. Iron oxide nanoparticles may damage to the neural tissue through iron accumulation, oxidative stress, and protein aggregation. BMC Neurosci. 2017;18(1):51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5485499</ArticleId><ArticleId IdType="pubmed">28651647</ArticleId></ArticleIdList></Reference><Reference><Citation>Teller S, et al. Magnetite-Amyloid-&#x3b2; deteriorates activity and functional organization in an in vitro model for Alzheimer&#x2019;s disease. Sci Rep. 2015;5:17261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4660300</ArticleId><ArticleId IdType="pubmed">26608215</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M, et al. Implications for blood-brain-barrier permeability, in vitro oxidative stress and neurotoxicity potential induced by mesoporous silica nanoparticles: effects of surface modification. RSC Adv. 2016;6(4):2800&#x2013;2809.</Citation></Reference><Reference><Citation>You R, et al. Silica nanoparticles induce neurodegeneration-like changes in behavior, neuropathology, and affect synapse through MAPK activation. Part Fibre Toxicol. 2018;15(1):28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6029039</ArticleId><ArticleId IdType="pubmed">29970116</ArticleId></ArticleIdList></Reference><Reference><Citation>Distasi C, et al. SiO(2) nanoparticles modulate the electrical activity of neuroendocrine cells without exerting genomic effects. Sci Rep. 2018;8(1):2760.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5807366</ArticleId><ArticleId IdType="pubmed">29426889</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, et al. SiO2 nanoparticles change colour preference and cause Parkinson's-like behaviour in zebrafish. Sci Rep. 2014;4:3810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3898208</ArticleId><ArticleId IdType="pubmed">24448416</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, et al. Uptake of silica nanoparticles: neurotoxicity and Alzheimer-like pathology in human SK-N-SH and mouse neuro2a neuroblastoma cells. Toxicol Lett. 2014;229(1):240&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pubmed">24831964</ArticleId></ArticleIdList></Reference><Reference><Citation>Song B, et al. Unraveling the neurotoxicity of titanium dioxide nanoparticles: focusing on molecular mechanisms. Beilstein J Nanotechnol. 2016;7:645&#x2013;654.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4901937</ArticleId><ArticleId IdType="pubmed">27335754</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T, Tang M. The inflammatory response to silver and titanium dioxide nanoparticles in the central nervous system. Nanomedicine. 2018;13(2):233&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pubmed">29199887</ArticleId></ArticleIdList></Reference><Reference><Citation>Disdier C, et al. Brain inflammation, blood brain barrier dysfunction and neuronal synaptophysin decrease after inhalation exposure to titanium dioxide nano-aerosol in aging rats. Sci Rep. 2017;7(1):1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5610323</ArticleId><ArticleId IdType="pubmed">28939873</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder&#xf3;n-Garcidue&#xf1;as L, et al. Hallmarks of Alzheimer disease are evolving relentlessly in Metropolitan Mexico City infants, children and young adults. APOE4 carriers have higher suicide risk and higher odds of reaching NFT stage V at &#x2264; 40 years of age. Environ Res. 2018;164:475&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pubmed">29587223</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder&#xf3;n-Garcidue&#xf1;as L, et al. Gait and balance disturbances are common in young urbanites and associated with cognitive impairment. Air pollution and the historical development of Alzheimer's disease in the young. Environ Res. 2020;191:110087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7467072</ArticleId><ArticleId IdType="pubmed">32890478</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SH, et al. Rapid doubling of Alzheimer's amyloid-&#x3b2;40 and 42 levels in brains of mice exposed to a nickel nanoparticle model of air pollution. F1000Res. 2012;1:70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3782349</ArticleId><ArticleId IdType="pubmed">24358824</ArticleId></ArticleIdList></Reference><Reference><Citation>Purdey M. Elevated levels of ferrimagnetic metals in foodchains supporting the Guam cluster of neurodegeneration: do metal nucleated crystal contaminants [corrected] evoke magnetic fields that initiate the progressive pathogenesis of neurodegeneration? Med Hypotheses. 2004;63(5):793&#x2013;809.</Citation><ArticleIdList><ArticleId IdType="pubmed">15488650</ArticleId></ArticleIdList></Reference><Reference><Citation>Afitska K, et al. (2019) &#x3b1;-Synuclein aggregation at low concentrations. Biochim Biophys Acta Proteins Proteom. 1867;7&#x2013;8:701&#x2013;709.</Citation><ArticleIdList><ArticleId IdType="pubmed">31096048</ArticleId></ArticleIdList></Reference><Reference><Citation>Coufal&#xed;k P, et al. Content of metals in emissions from gasoline, diesel, and alternative mixed biofuels. Environ Sci Pollut Res Int. 2019;26(28):29012&#x2013;29019.</Citation><ArticleIdList><ArticleId IdType="pubmed">31388949</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonntag DB, et al. Contribution of lubricating oil to particulate matter emissions from light-duty gasoline vehicles in Kansas City. Environ Sci Technol. 2012;46(7):4191&#x2013;4199.</Citation><ArticleIdList><ArticleId IdType="pubmed">22369074</ArticleId></ArticleIdList></Reference><Reference><Citation>Casado JE, et al. Unctuous ZrO(2) nanoparticles with improved functional attributes as lubricant additives. Nanotechnology. 2017;28(49):495704.</Citation><ArticleIdList><ArticleId IdType="pubmed">29035276</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasar A, et al. A comparison of waste recycling facilities for their contribution of heavy metals and trace elements in ambient air. Environ Sci Pollut Res Int. 2021;28:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">33394427</ArticleId></ArticleIdList></Reference><Reference><Citation>Cenci MP, et al. Precious and critical metals from wasted LED lamps: characterization and evaluation. Environ Technol. 2020;10:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">33241733</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhagat J, et al. Toxicological interactions of microplastics/nanoplastics and environmental contaminants: current knowledge and future perspectives. J Hazard Mater. 2021;405:123913.</Citation><ArticleIdList><ArticleId IdType="pubmed">33127190</ArticleId></ArticleIdList></Reference><Reference><Citation>Okeme JO, Arrandale VH. Electronic waste recycling: occupational exposures and work-related health effects. Curr Environ Health Rep. 2019;6(4):256&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pubmed">31734812</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghoshdastidar AJ, Ariya PA. The existence of airborne mercury nanoparticles. Sci Rep. 2019;9(1):10733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6656720</ArticleId><ArticleId IdType="pubmed">31341248</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardoso CED, et al. Recovery of rare earth elements by carbon-based nanomaterials&#x2014;a review. Nanomaterials (Basel) 2019;9(6):814.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6630350</ArticleId><ArticleId IdType="pubmed">31146505</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x17d;ivan&#x10d;evi&#x107; K, et al. Elucidating the influence of environmentally relevant toxic metal mixture on molecular mechanisms involved in the development of neurodegenerative diseases: In silico toxicogenomic data-mining. Environ Res. 2021;194:110727.</Citation><ArticleIdList><ArticleId IdType="pubmed">33465344</ArticleId></ArticleIdList></Reference><Reference><Citation>Hang BT, Anh TT. Controlled synthesis of various Fe(2)O(3) morphologies as energy storage materials. Sci Rep. 2021;11(1):5185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7933284</ArticleId><ArticleId IdType="pubmed">33664404</ArticleId></ArticleIdList></Reference><Reference><Citation>Oggiano R, et al. An overview on amyotrophic lateral sclerosis and cadmium. Neurol Sci. 2021;42(2):531&#x2013;537.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7843544</ArticleId><ArticleId IdType="pubmed">33280067</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos E, et al. Amyotrophic lateral sclerosis after exposure to manganese from traditional medicine procedures in Kenya. Biol Trace Elem Res. 2020;199:3618&#x2013;3624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8360856</ArticleId><ArticleId IdType="pubmed">33230634</ArticleId></ArticleIdList></Reference><Reference><Citation>Engin AB. Combined toxicity of metal nanoparticles: comparison of individual and mixture particles effect. Adv Exp Med Biol. 2021;1275:165&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pubmed">33539016</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder&#xf3;n-Garcidue&#xf1;as L, et al. Air pollution and brain damage. Toxicol Pathol. 2002;30(3):373&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pubmed">12051555</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesauro M, et al. Metal(loid)s role in the pathogenesis of amyotrophic lateral sclerosis: environmental, epidemiological, and genetic data. Environ Res. 2021;192:110292.</Citation><ArticleIdList><ArticleId IdType="pubmed">33027627</ArticleId></ArticleIdList></Reference><Reference><Citation>National Research Council Committee for Review of the, D.s.E.P.M.S.P.R. (2010) In Review of the Department of Defense Enhanced Particulate Matter Surveillance Program Report, National Academies Press (US). Copyright 2010 by the National Academy of Sciences. All rights reserved</Citation><ArticleIdList><ArticleId IdType="pubmed">24983028</ArticleId></ArticleIdList></Reference><Reference><Citation>Olvera HA, et al. Ultrafine particle levels at an international port of entry between the US and Mexico: exposure implications for users, workers, and neighbors. J Expo Sci Environ Epidemiol. 2013;23(3):289&#x2013;298.</Citation><ArticleIdList><ArticleId IdType="pubmed">23321858</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero-Beltr&#xe1;n CE, et al. Silica nanoparticles induce cardiotoxicity interfering with energetic status and Ca(2+) handling in adult rat cardiomyocytes. Am J Physiol Heart Circ Physiol. 2017;312(4):H645&#x2013;h661.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5407167</ArticleId><ArticleId IdType="pubmed">28130337</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim&#xf3;n-Pacheco JH, et al. Astrocytes are more vulnerable than neurons to silicon dioxide nanoparticle toxicity in vitro. Toxics. 2020;8(3):51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7560395</ArticleId><ArticleId IdType="pubmed">32751182</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei J, et al. Low-dose exposure of silica nanoparticles induces neurotoxicity via neuroactive ligand-receptor interaction signaling pathway in Zebrafish embryos. Int J Nanomedicine. 2020;15:4407&#x2013;4415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7310985</ArticleId><ArticleId IdType="pubmed">32606685</ArticleId></ArticleIdList></Reference><Reference><Citation>Lojk J, et al. Toxicity mechanisms of selected engineered nanoparticles on human neural cells in vitro. Toxicology. 2020;432:152364.</Citation><ArticleIdList><ArticleId IdType="pubmed">31927068</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulati K, et al. Nanoengineered drug-releasing Ti wires as an alternative for local delivery of chemotherapeutics in the brain. Int J Nanomedicine. 2012;7:2069&#x2013;2076.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3356184</ArticleId><ArticleId IdType="pubmed">22619543</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiner MW, et al. Military risk factors for Alzheimer&#x2019;s disease. Alzheimers Dement. 2013;9(4):445&#x2013;451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5904389</ArticleId><ArticleId IdType="pubmed">23809365</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyburn L, et al. The role of TDP-43 in military-relevant TBI and chronic neurodegeneration. Front Neurol. 2019;10:680.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6610302</ArticleId><ArticleId IdType="pubmed">31316455</ArticleId></ArticleIdList></Reference><Reference><Citation>Weedn VW. Origins of the armed forces medical examiner system. Acad Forensic Pathol. 2020;10(1):16&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7495678</ArticleId><ArticleId IdType="pubmed">32983291</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady CB, et al. The Department of Veterans Affairs Biorepository Brain Bank: a national resource for amyotrophic lateral sclerosis research. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(7&#x2013;8):591&#x2013;597.</Citation><ArticleIdList><ArticleId IdType="pubmed">23971854</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Leary MC, et al. Development of a multi-study repository to support research on veteran health: the VA Cooperative Studies Program Epidemiology Center-Durham (CSPEC-Durham) Data and Specimen Repository. Front Public Health. 2021;9:612806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7925406</ArticleId><ArticleId IdType="pubmed">33681131</ArticleId></ArticleIdList></Reference><Reference><Citation>Obermann M, Lyon M. Financial cost of amyotrophic lateral sclerosis: a case study. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(1&#x2013;2):54&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">25245119</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>